Daboia siamensis venom toxins (DSV toxins)

Daboia siamensis venom toxins, formerly classified under Vipera russelli siamensis, comprise a lethal cocktail of proteins and peptides secreted by the Eastern Russell's viper. The venom is characterized by its complex hemotoxic, neurotoxic, and myotoxic properties, primarily driven by major toxin families such as phospholipases A2 (PLA2), snake venom metalloproteinases (SVMP), and serine proteases (SVSP). These components work synergistically to activate blood coagulation factors (notably Factor X and Factor V), leading to severe consumptive coagulopathy and systemic hemorrhage. In certain regions, the presence of potent PLA2 isoforms like daboiatoxin also induces pre-synaptic neurotoxicity and muscle necrosis. Clinically, envenomation is a medical emergency often resulting in acute renal failure and tissue damage. Therapeutic management relies on specific antivenoms that neutralize these toxins, though research into small-molecule inhibitors like varespladib offers promising adjunct treatments to mitigate specific toxic effects such as PLA2-mediated neurotoxicity.

Other names

Vipera russelli siamensis venom toxinsEastern Russell's viper venom toxinsSiamese Russell's viper venomDaboia russelii siamensis venom

Antivenom antibodies bind to and neutralize the various enzymatic and non-enzymatic toxins in the venom, preventing their interaction with physiological targets. Small-molecule inhibitors like varespladib specifically inhibit the enzymatic activity of phospholipase A2 (PLA2) isoforms, while metalloproteinase inhibitors like prinomastat target the zinc-dependent catalytic sites of SVMPs.